Wenshu XiangWei

Wenshu XiangWei

Auto-generated profile, based on publicly available information

Wenshu XiangWei

Department of Pediatrics and Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2019 in Brain
Verified
Journal Article
Closed access
WXWenshu XiangWei
Wenshu XiangWei
VKVarun Kannan
Varun Kannan
YXYuchen Xu
Yuchen Xu
GKGabrielle J Kosobucki
Gabrielle J Kosobucki
ASAnthony J Schulien
Anthony J Schulien
YJYuwu Jiang
Yuwu Jiang
NMDA receptors are implicated in various neurological diseases. XiangWei et al. identify seven GRIN2D variants associated with developmental and epileptic encephalopathy. They describe the clinical phenotypes and evaluate functional changes, including pharmacological properties, surface trafficking, and neurotoxicity, as well as the responses to FDA-approved NMDAR drugs for potential rescue pharmacology.

5 May 2020 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
JPJuliette Piard
Juliette Piard
MBMatthieu BEREAU
Matthieu BEREAU
WXWenshu XiangWei
Wenshu XiangWei
TWThomas Wirth
Thomas Wirth
DADaniel Amsallem
Daniel Amsallem
HYHongjie Yuan
Hongjie Yuan

3 November 2023 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
WXWenshu XiangWei
Wenshu XiangWei
RPRiley E. Perszyk
Riley E. Perszyk
NLNana Liu
Nana Liu
YXYuchen Xu
Yuchen Xu
SBSubhrajit Bhattacharya
Subhrajit Bhattacharya
STStephen F. Traynelis
Stephen F. Traynelis

15 July 2025 in BMC Neuroscience
Verified
Journal Article
Open access
JZJunjiao Zhang
Junjiao Zhang
WXWenshu XiangWei
Wenshu XiangWei
FZFan Zhang
Fan Zhang
HYHuan Yi
Huan Yi
WYWei Yan
Wei Yan
YJYuwu Jiang
Yuwu Jiang
Tamibarotene, a synthetic retinoid used in the treatment of acute promyelocytic leukemia, has been reported to induce differentiation in the SH-SY5Y cell line into neurons. However, the underlying mechanisms remain unclear. This study aimed to determine the optimal concentration of Tamibarotene (Am80) for promoting neuronal differentiation and to elucidate the underlying molecular mechanisms. SH-SY5Y cells were treated with Am80 at various concentrations, and the effects on cell morphology, gene expression, cell proliferation and apoptosis assessed using immunofluorescence, Western blotting, qPCR, and RNA sequencing. Results indicated that that 1µM Am80 effectively promoted neuronal differentiation, upregulating neuronal markers and the KCNT1 gene, while downregulating tumor-related genes MYC and CXCR4. The differentially expressed genes are predominantly enriched in the PI3K-Akt signaling pathway, with upregulation of genes related to neuronal development such as NTRK2, RET, and CNR1, and downregulation of tumor-related genes including MYC and CXCR4. Inhibition of the PI3K/Akt signaling pathway using LY294002 resulted in a decreased efficacy of AM80-induced differentiation in SH-SY5Y cells, along with downregulation of neuronal marker expression. These findings suggest that Am80 can effectively promote the differentiation of SH-SY5Y cells into neurons and reduce the proliferation of neuroblastoma cells, which is related to the PI3K/AKT pathway, providing a good model for the study of nervous system diseases.